What is he best known for?
The fields of study he is best known for:
- Bacteria
- Antibiotics
- Gene
Antibiotic resistance, Antibiotics, Microbiology, Drug resistance and Acinetobacter baumannii are his primary areas of study.
His Antibiotic resistance research integrates issues from Natural selection, Genetic Fitness and Cephalosporin.
His Antibiotics research includes elements of Antimicrobial, Computational biology, Fitness landscape, Avibactam and Pharmacology.
His studies in Microbiology integrate themes in fields like Serratia marcescens, Virology and Bacteria.
The study incorporates disciplines such as Vaborbactam, Ampicillin, Ticarcillin and Sulbactam in addition to Drug resistance.
His research investigates the connection with Acinetobacter baumannii and areas like Bacteremia which intersect with concerns in Intensive care medicine, Clinical trial, Observational study and Sepsis.
His most cited work include:
- Extended-spectrum beta-lactamases: a clinical update. (2456 citations)
- Three Decades of β-Lactamase Inhibitors (1051 citations)
- Three Decades of β-Lactamase Inhibitors (1051 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Antibiotic resistance, Klebsiella pneumoniae, Antibiotics and Acinetobacter baumannii.
His Microbiology study incorporates themes from Gene, Enterobacteriaceae and Escherichia coli.
His biological study spans a wide range of topics, including Efflux, Computational biology and Drug resistance.
In his research, Horizontal gene transfer is intimately related to Plasmid, which falls under the overarching field of Klebsiella pneumoniae.
His work deals with themes such as Ceftazidime, Ceftazidime/avibactam and Avibactam, which intersect with Antibiotics.
Robert A. Bonomo has included themes like Ampicillin, Ticarcillin, Sulbactam and Beta-Lactamase Inhibitors in his Pharmacology study.
He most often published in these fields:
- Microbiology (39.35%)
- Antibiotic resistance (23.23%)
- Klebsiella pneumoniae (18.06%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (39.35%)
- Klebsiella pneumoniae (18.06%)
- Antibiotic resistance (23.23%)
In recent papers he was focusing on the following fields of study:
Robert A. Bonomo mostly deals with Microbiology, Klebsiella pneumoniae, Antibiotic resistance, Internal medicine and Acinetobacter baumannii.
His Microbiology research is multidisciplinary, incorporating perspectives in Gene, Enterobacteriaceae and Carbapenem resistant.
The Antibiotic resistance study which covers β lactamases that intersects with Signal transduction.
His Internal medicine research includes themes of Multilocus sequence typing and Drug resistance.
His research in Drug resistance intersects with topics in Ceftolozane, Tazobactam, Aminoglycoside, Pharmacology and Polymyxin.
His biological study focuses on Cephalosporin.
Between 2017 and 2021, his most popular works were:
- A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World. (36 citations)
- Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa (34 citations)
- Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study (23 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Antibiotics
- Gene
Microbiology, Antibiotic resistance, Klebsiella pneumoniae, Carbapenem resistant and Genetics are his primary areas of study.
His Microbiology study integrates concerns from other disciplines, such as Carbapenem-resistant enterobacteriaceae and Gene, Virulence.
His Antibiotic resistance research is classified as research in Antibiotics.
His research integrates issues of Internal medicine, Prospective cohort study, In silico and Acinetobacter baumannii in his study of Klebsiella pneumoniae.
His study on Genotype, Susceptibility testing, Phenotype and Agar dilution is often connected to Breakpoint as part of broader study in Genetics.
His work focuses on many connections between Gram-negative bacteria and other disciplines, such as Siderophore, that overlap with his field of interest in Cephalosporin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
